17 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ANTO | UK£16.65 | -0.9% | 17.8% | UK£16.4b | UK£19.61 | PE26.9x | E18.3% | 1.5% | Materials | ||
AAL | UK£23.59 | 1.8% | 7.0% | UK£28.6b | UK£25.60 | PS1.2x | E49.1% | 2.8% | Materials | ||
SGRO | UK£7.73 | 2.1% | -5.7% | UK£10.4b | UK£9.80 | PB0.9x | E37.9% | 3.7% | Real Estate | ||
BATS | UK£29.69 | 3.0% | 16.5% | UK£65.5b | UK£31.30 | PS2.5x | E44.2% | 7.9% | Food, Beverage & Tobacco | ||
GLEN | UK£3.81 | -0.7% | -14.5% | UK£46.3b | UK£5.09 | PS0.3x | E42.0% | 2.7% | Materials | ||
INF | UK£8.75 | 2.3% | 17.2% | UK£11.6b | UK£9.91 | PE36.9x | E22.4% | 2.1% | Media | ||
BP. | UK£3.93 | 1.4% | -17.3% | UK£61.6b | UK£5.09 | PE28.4x | E28.5% | 6.5% | Energy | ||
GSK | UK£13.42 | 2.4% | -5.1% | UK£54.8b | UK£18.55 | PE21.8x | E21.9% | 4.3% | Pharmaceuticals & Biotech | ||
REL | UK£37.23 | 4.4% | 21.2% | UK£69.1b | UK£39.78 | PE36.5x | E8.1% | 1.6% | Commercial Services | ||
AZN | UK£104.74 | 5.6% | 5.0% | UK£162.4b | UK£140.72 | PE31.3x | E18.4% | 2.2% | Pharmaceuticals & Biotech | ||
PRU | UK£6.35 | -0.8% | -30.1% | UK£16.9b | UK£11.60 | PE24.1x | E28.4% | 2.6% | Insurance | ||
RTO | UK£4.07 | 0.6% | -9.4% | UK£10.2b | UK£4.60 | PE26.1x | E15.1% | 2.2% | Commercial Services | ||
SN. | UK£9.87 | 0.6% | -3.4% | UK£8.6b | UK£12.80 | PE35.4x | E22.5% | 3.0% | Healthcare | ||
CCH | UK£27.98 | 1.1% | 28.3% | UK£10.1b | UK£29.07 | PE19.3x | E11.9% | 2.8% | Food, Beverage & Tobacco | ||
III | UK£35.69 | 3.2% | 63.0% | UK£34.4b | UK£37.42 | PE8.2x | E17.7% | 1.8% | Diversified Financials | ||
KSPI | US$120.60 | 5.4% | 59.9% | US$22.8b | US$130.21 | PE12.2x | E17.0% | 6.3% | Diversified Financials | ||
NXT | UK£97.64 | 3.4% | 24.8% | UK£11.6b | UK£101.15 | PE14.4x | E2.6% | 2.1% | Retail |
Page 1 of 1